DE69733268D1 - Mittel zur transdermalen verabreichung von arzneistoffen - Google Patents

Mittel zur transdermalen verabreichung von arzneistoffen

Info

Publication number
DE69733268D1
DE69733268D1 DE69733268T DE69733268T DE69733268D1 DE 69733268 D1 DE69733268 D1 DE 69733268D1 DE 69733268 T DE69733268 T DE 69733268T DE 69733268 T DE69733268 T DE 69733268T DE 69733268 D1 DE69733268 D1 DE 69733268D1
Authority
DE
Germany
Prior art keywords
drug
medicaments
medium
transdermal administration
carrier
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69733268T
Other languages
English (en)
Other versions
DE69733268T2 (de
Inventor
Risto Jaernstroem
Jouni Hirvonen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NOVAGENT KAUNIAINEN Oy
Original Assignee
NOVAGENT KAUNIAINEN Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FI960435A external-priority patent/FI960435A/fi
Priority claimed from FI962450A external-priority patent/FI962450A0/fi
Application filed by NOVAGENT KAUNIAINEN Oy filed Critical NOVAGENT KAUNIAINEN Oy
Application granted granted Critical
Publication of DE69733268D1 publication Critical patent/DE69733268D1/de
Publication of DE69733268T2 publication Critical patent/DE69733268T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69733268T 1996-01-30 1997-01-27 Zusammensetzung für die kontrollierte Freisetzung eines Arzneimittels bei der transdermalen Verabreichung Expired - Lifetime DE69733268T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
FI960435 1996-01-30
FI960435A FI960435A (fi) 1996-01-30 1996-01-30 Lääkkeiden transdermaalisen antotapaan tarkoitettu koostumus
FI962450A FI962450A0 (fi) 1996-06-12 1996-06-12 Farmaceutisk sammansaettning och foerfarande foer dosering av laekemedel
FI962450 1996-06-12
PCT/FI1997/000039 WO1997027844A1 (en) 1996-01-30 1997-01-27 Composition for transdermal delivery of drugs

Publications (2)

Publication Number Publication Date
DE69733268D1 true DE69733268D1 (de) 2005-06-16
DE69733268T2 DE69733268T2 (de) 2006-01-19

Family

ID=26160098

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69733268T Expired - Lifetime DE69733268T2 (de) 1996-01-30 1997-01-27 Zusammensetzung für die kontrollierte Freisetzung eines Arzneimittels bei der transdermalen Verabreichung

Country Status (7)

Country Link
US (1) US6254883B1 (de)
EP (1) EP0942716B1 (de)
JP (1) JP2000504002A (de)
AT (1) ATE295157T1 (de)
CA (1) CA2242753A1 (de)
DE (1) DE69733268T2 (de)
WO (1) WO1997027844A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI107372B (fi) * 1999-04-29 2001-07-31 Novagent Oy Laite vaikuttavan aineen annosteluun ja annostelun tutkimukseen
WO2003068158A2 (en) * 2002-02-13 2003-08-21 Van Beek Global/Ninkov L.L.C. Compositions and methods for increasing milk production in animals
WO2007078007A1 (ja) * 2006-01-06 2007-07-12 Japan Science And Technology Agency カーボンナノホーン構造体並びにその内在有機物の放出を制御可能とする組成物とその方法
JP5558096B2 (ja) 2007-03-01 2014-07-23 株式会社日本触媒 吸水性樹脂を主成分とする粒子状吸水剤
CN101641153B (zh) 2007-04-05 2012-08-15 株式会社日本触媒 以吸水性树脂为主成分的粒子状吸水剂
KR20150023923A (ko) * 2010-07-30 2015-03-05 이엠디 밀리포어 코포레이션 크로마토그래피 매질 및 방법
FI125075B (fi) * 2012-08-13 2015-05-29 Novagent Oy Vaikuttavan aineen iontoforeettinen annostelujärjestelmä
US20150374775A1 (en) * 2013-04-10 2015-12-31 Glycobiosciences Inc. Topical nutraceutical composition
CN106794389A (zh) 2014-09-02 2017-05-31 Emd密理博公司 具有纳米原纤化表面特征的高表面积纤维介质
EP3212173A4 (de) 2014-10-30 2018-06-20 Textile-Based Delivery, Inc. Verabreichungssysteme
SG11201703399QA (en) 2014-12-08 2017-05-30 Emd Millipore Corp Mixed bed ion exchange adsorber
EP4171671A1 (de) * 2020-06-24 2023-05-03 Anika Therapeutics, Inc. Medizinische verbundtextilie mit nichtresorbierbaren fasern und bioresorbierbaren hyaluronanbasierten fasern

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE603705C (de) 1931-06-18 1934-10-08 Desider Deutsch Dr Elektrode zur Einfuehrung von Heilmitteln in den Koerper mittels Iontophorese
FI52816C (fi) 1974-03-28 1983-05-10 Exel Oy Trissa foer skidstav
US4032452A (en) 1975-11-13 1977-06-28 Sybron Corporation Electrically regenerated ion exchange system
US4585652A (en) 1984-11-19 1986-04-29 Regents Of The University Of Minnesota Electrochemical controlled release drug delivery system
US4692462A (en) 1985-03-18 1987-09-08 Menley & James Laboratories, Ltd. Compositions and method of controlling transdermal penetration of topical and systemic agents
US4731049A (en) 1987-01-30 1988-03-15 Ionics, Incorporated Cell for electrically controlled transdermal drug delivery
US5080646A (en) 1988-10-03 1992-01-14 Alza Corporation Membrane for electrotransport transdermal drug delivery
US5162042A (en) 1988-07-05 1992-11-10 Alza Corporation Electrotransport transdermal system
US5098417A (en) 1990-04-12 1992-03-24 Ricoh Kyosan, Inc. Cellulosic wound dressing with an active agent ionically absorbed thereon
US5147297A (en) 1990-05-07 1992-09-15 Alza Corporation Iontophoretic delivery device
ZA921736B (en) 1991-03-11 1992-11-25 Alza Corp Iontophoretic delivery device and method of making same
WO1994008572A1 (en) 1992-10-15 1994-04-28 Alza Corporation Delayed onset transdermal delivery device
US5603955A (en) 1994-07-18 1997-02-18 University Of Cincinnati Enhanced loading of solutes into polymer gels
JP2001520527A (ja) 1994-09-30 2001-10-30 ベクトン・ディッキンソン・アンド・カンパニー 使い捨てパッチと再使用可能で取り外し可能なコントローラーとを包含するイオン導入式薬物投与系
US5894021A (en) 1994-09-30 1999-04-13 Kabushiki Kaisya Advance Iontophoretic transdermal drug-delivery interface and skin treatment agent and treatment method using the same

Also Published As

Publication number Publication date
ATE295157T1 (de) 2005-05-15
WO1997027844A1 (en) 1997-08-07
EP0942716B1 (de) 2005-05-11
DE69733268T2 (de) 2006-01-19
JP2000504002A (ja) 2000-04-04
EP0942716A1 (de) 1999-09-22
US6254883B1 (en) 2001-07-03
CA2242753A1 (en) 1997-08-07

Similar Documents

Publication Publication Date Title
DE3879853D1 (de) Klebstoffzusammensetzung, zusammensetzung mit kontrollierter wirkstofffreisetzung und system zur transdermalen anwendung von arzneien.
DE69506007T2 (de) Transdermales system zur gleichzeitigen verabreichung von mehreren wirkstoffen
DK288987A (da) Et afgivelsessystem til doseringsformerne forhalet afgivelse, samt dettes fremstilling
DE69733268D1 (de) Mittel zur transdermalen verabreichung von arzneistoffen
MX9600857A (es) Forma de dosificacion i en tabletas, con unidades multiples.
MY105121A (en) Pharmaceutical composition for systemic transdermal administration.
NZ236002A (en) Transdermal delivery system for 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzothiazole
CA2110161A1 (en) Medetomidine preparations for transdermal administration
ES2016620B3 (es) Sistema para liberar medicamentos con bioaceptabilidad mejorada.
TW374729B (en) 4-biphenylylacetate-containing medicated plaster
DE69633396D1 (de) Activin stimulator enthaltende pharmazeutische zusammensetzung
DK0825865T3 (da) Transdermalt, terapeutisk system for administrering af testosteron eller testosteronderivat
ATE280575T1 (de) Transdermales therapeutisches system zur anwendung von candesartan
DE69803670T2 (de) Tiagabinhaltige arzneizubereitungen mit gesteuerter wirkstoffverabreichung
AU2907800A (en) Pharmaceutical composition containing desoxypeganine for the treatment of alcoholism
NO963143D0 (no) Oral legemiddelform inneholdende colestipol som bærer med sure virkestoffer og fremgangsmåte ved fremstilling av denne
DE59510583D1 (de) Pharmazeutische zusammensetzung zur systemischen transdermalen verabreichung mit dem wirkstoff morphin-6-glucuronid
DE60028207D1 (de) Transdermales therapeutisches system zur verabreichung von calciumantagonisten
DE69727222D1 (de) Zusammensetzung und system zur iontophoretischen transdermalen abgabe von medikamenten
DE69717279D1 (de) Mittel gegen malaria und babesia und diese enthaltende pfarmazeutische zubereitungen
YU71293A (sh) Transdermalni terapijski sistem za davanje fizostigmina na koži i postupak za njegovu izradu
BR9808876A (pt) Sistema de liberação de medicamento
JO1880B1 (en) Format 1 for multi-unit calibration discs
JO1881B1 (en) Formula II for multi unit disc calibration
UA37510A (uk) Спосіб лікування загрози передчасного переривання вагітності

Legal Events

Date Code Title Description
8364 No opposition during term of opposition